Although no NF-κB pathway gene signature was detected for the TAL1-positive subgroup, other work showed that TAL1 protein expression in T-ALL cells can control NF-κB activity through direct NFKB1 promoter repression [91]. The gene discussed is TAL1; the disease is acute lymphoblastic leukemia.